Free Trial

ClearPoint Neuro (CLPT) Stock Price, News & Analysis

ClearPoint Neuro logo
$11.80 -0.22 (-1.83%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$11.82 +0.02 (+0.20%)
As of 06/27/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About ClearPoint Neuro Stock (NASDAQ:CLPT)

Key Stats

Today's Range
$11.40
$12.03
50-Day Range
$11.17
$14.71
52-Week Range
$5.11
$19.22
Volume
4.10 million shs
Average Volume
263,392 shs
Market Capitalization
$330.28 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$25.00
Consensus Rating
Buy

Company Overview

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

ClearPoint Neuro Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
49th Percentile Overall Score

CLPT MarketRank™: 

ClearPoint Neuro scored higher than 49% of companies evaluated by MarketBeat, and ranked 606th out of 941 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    ClearPoint Neuro has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    ClearPoint Neuro has only been the subject of 1 research reports in the past 90 days.

  • Read more about ClearPoint Neuro's stock forecast and price target.
  • Earnings Growth

    Earnings for ClearPoint Neuro are expected to grow in the coming year, from ($0.66) to ($0.59) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of ClearPoint Neuro is -15.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of ClearPoint Neuro is -15.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    ClearPoint Neuro has a P/B Ratio of 12.83. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about ClearPoint Neuro's valuation and earnings.
  • Percentage of Shares Shorted

    4.57% of the float of ClearPoint Neuro has been sold short.
  • Short Interest Ratio / Days to Cover

    ClearPoint Neuro has a short interest ratio ("days to cover") of 4.3.
  • Change versus previous month

    Short interest in ClearPoint Neuro has recently increased by 10.19%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    ClearPoint Neuro does not currently pay a dividend.

  • Dividend Growth

    ClearPoint Neuro does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.57% of the float of ClearPoint Neuro has been sold short.
  • Short Interest Ratio / Days to Cover

    ClearPoint Neuro has a short interest ratio ("days to cover") of 4.3.
  • Change versus previous month

    Short interest in ClearPoint Neuro has recently increased by 10.19%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    ClearPoint Neuro has a news sentiment score of 1.90. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.94 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for ClearPoint Neuro this week, compared to 2 articles on an average week.
  • Search Interest

    Only 3 people have searched for CLPT on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added ClearPoint Neuro to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, ClearPoint Neuro insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $415,173.00 in company stock.

  • Percentage Held by Insiders

    Only 6.97% of the stock of ClearPoint Neuro is held by insiders.

  • Percentage Held by Institutions

    Only 30.08% of the stock of ClearPoint Neuro is held by institutions.

  • Read more about ClearPoint Neuro's insider trading history.
Receive CLPT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ClearPoint Neuro and its competitors with MarketBeat's FREE daily newsletter.

CLPT Stock News Headlines

ClearPoint Neuro: Consumables Growth Is Promising
The $7 company helping Nvidia build the world’s first trillion-dollar robot …
Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profitable trends in tech … well ahead of Wall Street. Like when he called Nvidia at a mere 80 cents a share. Or Bitcoin when it was trading for just $300. Throughout his illustrious career … Michael has given his followers almost 150 different chances to register triple-digit gains.
ClearPoint Neuro, Inc. (CLPT): A Bull Case Theory
See More Headlines

CLPT Stock Analysis - Frequently Asked Questions

ClearPoint Neuro's stock was trading at $15.38 at the beginning of 2025. Since then, CLPT shares have decreased by 23.3% and is now trading at $11.80.
View the best growth stocks for 2025 here
.

ClearPoint Neuro, Inc. (NASDAQ:CLPT) announced its earnings results on Tuesday, May, 13th. The company reported ($0.22) earnings per share for the quarter, missing analysts' consensus estimates of ($0.15) by $0.07. The firm earned $8.49 million during the quarter, compared to analyst estimates of $8.21 million. ClearPoint Neuro had a negative trailing twelve-month return on equity of 78.09% and a negative net margin of 64.51%.
Read the conference call transcript
.

ClearPoint Neuro's top institutional shareholders include Millennium Management LLC (2.65%), Brown Advisory Inc. (1.18%), Essex Investment Management Co. LLC (1.17%) and Goldman Sachs Group Inc. (0.92%). Insiders that own company stock include Joseph Michael Burnett, Joseph Burnett and Timothy T Richards.
View institutional ownership trends
.

Shares of CLPT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that ClearPoint Neuro investors own include Arista Networks (ANET), NVIDIA (NVDA), CrowdStrike (CRWD), Axon Enterprise (AXON), Advanced Micro Devices (AMD), Cadence Design Systems (CDNS) and Broadcom (AVGO).

Company Calendar

Last Earnings
5/13/2025
Today
6/28/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:CLPT
Employees
110
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$25.00
High Stock Price Target
$30.00
Low Stock Price Target
$20.00
Potential Upside/Downside
+111.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$18.91 million
Pretax Margin
-64.50%

Debt

Sales & Book Value

Annual Sales
$31.39 million
Price / Cash Flow
N/A
Book Value
$0.92 per share
Price / Book
12.83

Miscellaneous

Free Float
26,038,000
Market Cap
$330.28 million
Optionable
Optionable
Beta
0.93
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:CLPT) was last updated on 6/28/2025 by MarketBeat.com Staff
From Our Partners